BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2455112)

  • 1. Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension.
    Gregorini L; Perondi R; Grassi G; Saino A; Giannattasio C; Mancia G; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S126-8. PubMed ID: 2455112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
    Omvik P; Lund-Johansen P; Haugland H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S182-4. PubMed ID: 2455128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats.
    Pegram BL; Kobrin I; Sesoko S; Frohlich ED
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1016-23. PubMed ID: 6085359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
    Omvik P; Lund-Johansen P; Haugland H
    J Hypertens; 1988 Feb; 6(2):95-103. PubMed ID: 3351300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrendipine once daily compared with nicardipine in the treatment of mild to moderate hypertension.
    Palermo R; Conti V; Agostinelli MC; Ganzetti S; Racco F; Melappioni A; Pratillo G; Moretti S
    Clin Ther; 1990; 12(2):149-56. PubMed ID: 2354484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term hypotensive treatment with nitrendipine in mild to moderate essential hypertension: preliminary results of a placebo-controlled study versus atenolol.
    Palombo C; Marabotti C; Genovesi-Ebert A; Giuliano G; Giaconi S; Fommei E; Mezzasalma L; Ghione S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S90-5. PubMed ID: 2455153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of manidipine on renal hemodynamics in essential hypertensive patients: responses to acute stress.
    Maki M; Kawamura H; Hara K; Mitsubayashi H; Suzuki K; Itou S; Usui W; Yasugi T
    Blood Press Suppl; 1992; 3():106-13. PubMed ID: 1343277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
    Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Hypertens Suppl; 1984 Dec; 2(2):S49-56. PubMed ID: 6100877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.